Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome

被引：0

作者：

Sawara, Y. ^{[1
]}

Itabashi, M. ^{[1
]}

Kojima, C. ^{[1
]}

Tabata, H. ^{[1
]}

Kamei, D. ^{[1
]}

Kawanishi, K. ^{[1
]}

Moriyama, T. ^{[1
]}

Sugiura, H. ^{[1
]}

Tsukada, M. ^{[1
]}

Takei, T. ^{[1
]}

Ogawa, T. ^{[1
]}

Yoshida, T. ^{[1
]}

Arai, J. ^{[1
]}

Uchida, K. ^{[1
]}

Tsuchiya, K. ^{[1
]}

Nitta, K. ^{[1
]}

机构：

[1] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo 1628666, Japan

来源：

CLINICAL NEPHROLOGY | 2009年 / 72卷 / 01期

关键词：

minimal change nephritic syndrome; relapse; rituximab; remission; ANTI-CD20;

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Minimal change nephrotic syndrome (MCNS) usually is considered to have a good renal prognosis, but the frequency of relapses is a therapeutic challenge to physicians. The treatment of patients with multiple relapses remains a matter of controversy, because few controlled studies are available. We report the case of a 25-year-old man who experienced relapses of MCNS. Single-dose rituximab therapy (total dose 500 mg) was given during the fourth relapse. Complete remission occurred 10 days later, when no CD19/20-positive B cells were detected in the blood. This the first report of efficacy of single-dose rituximab therapy to treat multi-relapsing MCNS in an adult patient.

引用

页码：69 / 72

页数：4

共 50 条

[21] Rituximab therapy for steroid-dependent minimal change nephrotic syndrome
Gilbert, Rodney D.
Hulse, Eleanor
Rigden, Susan
PEDIATRIC NEPHROLOGY, 2006, 21 (11) : 1698 - 1700
[22] Rituximab therapy for steroid-dependent minimal change nephrotic syndrome
Rodney D. Gilbert
Eleanor Hulse
Susan Rigden
Pediatric Nephrology, 2006, 21 : 1698 - 1700
[23] EFFICACY AND SAFETY OF SINGLE-DOSE RITUXIMAB BIOSIMILAR IN INITIAL EPISODE OF PAEDIATRIC STEROID-SENSITIVE NEPHROTIC SYNDROME
Liu, Jialu
Shen, Qian
Xie, Li
Deng, Fang
Wang, Xiaowen
Liu, Cuihua
Sun, Shuzhen
Zhang, Ruifeng
Zhang, Aihua
Jiang, Xiaoyun
Qian, Biyun
Xu, Hong
PEDIATRIC NEPHROLOGY, 2023, 38 : S125 - S126
[24] Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome
Hiroshi Tanaka
Tohru Nakahata
Etsuro Ito
Pediatric Nephrology, 2004, 19 : 1055 - 1058
[25] High Albumin Clearance Predicts the Minimal Change Nephrotic Syndrome Relapse
Kuno, Hideaki
Kanzaki, Go
Sasaki, Takaya
Haruhara, Kotaro
Okabe, Masahiro
Yokote, Shinya
Koike, Kentaro
Tsuboi, Nobuo
Yokoo, Takashi
KIDNEY360, 2023, 4 (06): : 787 - 795
[26] Single-dose daily administration of cyclosporin A for refractory nephrotic syndrome
Kudo, M
Tsugawa, K
Tanaka, H
PEDIATRIC NEPHROLOGY, 2005, 20 (07) : 1021 - 1022
[27] Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome
Tanaka, H
Nakahata, T
Ito, E
PEDIATRIC NEPHROLOGY, 2004, 19 (09) : 1055 - 1058
[28] Single-dose daily administration of cyclosporin A for refractory nephrotic syndrome
Masanobu Kudo
Koji Tsugawa
Hiroshi Tanaka
Pediatric Nephrology, 2005, 20 : 1021 - 1022
[29] Efficacy of low-dose rituximab in minimal change disease and prevention of relapse
Zhang, Jian
Zhao, Hui
Li, Xiaoli
Qian, Rui
Gao, Peijuan
Lu, Shouyan
Ma, Zhigang
BMC NEPHROLOGY, 2023, 24 (01)
[30] Efficacy of low-dose rituximab in minimal change disease and prevention of relapse
Jian Zhang
Hui Zhao
Xiaoli Li
Rui Qian
Peijuan Gao
Shouyan Lu
Zhigang Ma
BMC Nephrology, 24

← 1 2 3 4 5 →